drugset / Trial / NCT03745300

Comparative Evaluation Of 1.2% Atorvastatin and 1.2% Simvastatin Gel Local Drug Delivery And Redelivery In Chronic Periodontitis Subjects With Diabetes Mellitus: A Randomized Controlled Clinical Trial.

NCT03745300

RandomizedParallel-groupDouble-blindTreatment

Summary

Statins are specific competitive inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, known for its hypolipidemic actions, possessing biologically significant anti-inflammatory and antioxidant properties, exerts anabolic effects on bone through expression of BMP - 2, have paved way in periodontal regeneration. The present study aims to evaluate and compare the efficacy of subgingivally delivered 1.2% Atorvastatin (ATV) and 1.2% Simvastatin (SMV) gel local drug delivery and redelivery systems as an adjunct to scaling and root planning (SRP) in chronic periodontitis (CP) subjects with diabetes mellitus(DM).

Timeline

Start
2017-03-03
Primary completion
2017-12-22
Completion
2017-12-22

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atorvastatin Small molecule 1.2 % Other
Comparator Simvastatin Small molecule 1.2 %

Indications